Carl Sterritt presentation at the Canaccord Genuity 36th Annual Growth Conference, Boston

12 Aug 2016

Shield Therapeutics attended the Canaccord Genuity 36th Annual Growth Conference on August 10th-11th, 2016, in Boston, MA.
Canaccord Genuity is a leading independent global investment bank focused on growth companies

Carl Sterritt, CEO of Shield Therapeutics, also presented at the conference on the 10th of August 2016.

For further information please visit the Canaccord website here.

To view the webcast of the event please click here.

Back to news